Men with poor-prognosis non-metastatic prostate cancer can be cured with adjuvant androgen deprivation therapy

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2006年 / 5卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：288 / 288
页数：1
相关论文
共 50 条
  • [1] Adjuvant androgen deprivation therapy offers a "CURE" in patients with poor prognosis non-metastatic prostate cancer
    Fleshner, N
    Keane, TE
    Lawton, CA
    Payne, H
    Mulders, PF
    Taneja, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S288 - S288
  • [2] Osteoporosis in men receiving androgen deprivation therapy for non-metastatic prostate cancer
    Kudlacek, Stefan
    Puntus, Thomas
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2012, 162 (17-18) : 380 - 385
  • [3] Is physical function affected by androgen deprivation therapy (ADT) in men with non-metastatic prostate cancer?
    Gogov, S.
    Hussain, F.
    Naglie, G.
    Tannock, I.
    Fleshner, N. E.
    Krahn, M. D.
    Canning, S. Duff
    Warde, P.
    Alibhai, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 245S - 245S
  • [4] Changes in cerebral metabolic activity in men undergoing androgen deprivation therapy for non-metastatic prostate cancer
    Cherrier, M. M.
    Cross, D. J.
    Higano, C. S.
    Minoshima, S.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2018, 21 (03) : 394 - 402
  • [5] Changes in cerebral metabolic activity in men undergoing androgen deprivation therapy for non-metastatic prostate cancer
    M. M. Cherrier
    D. J. Cross
    C. S. Higano
    S. Minoshima
    Prostate Cancer and Prostatic Diseases, 2018, 21 : 394 - 402
  • [6] ASSOCIATION BETWEEN ANDROGEN-DEPRIVATION THERAPY AND NON-PROSTATE CANCER MORTALITY AMONG MEN WITH NON-METASTATIC PROSTATE CANCER
    Wallis, Christopher
    Satkunasivam, Raj
    Herschorn, Sender
    Law, Calvin
    Seth, Arun
    Kodama, Ronald
    Kulkarni, Girish
    Nam, Robert
    JOURNAL OF UROLOGY, 2018, 199 (04): : E274 - E275
  • [7] Changes in blood glucose and cholesterol levels due to androgen deprivation therapy in men with non-metastatic prostate cancer
    Mohamedali, Hassanabbas Z.
    Breunis, Henriette
    Timilshina, Narhari
    Alibhai, Shabbir M. H.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2011, 5 (01): : 28 - 32
  • [8] The role of androgen deprivation therapy plus radiation therapy in patients with non-metastatic prostate cancer
    Zhao, Sherry
    Urdaneta, Alfredo I.
    Anscher, Mitchell S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (09) : 929 - 942
  • [9] THE EFFECT OF ANDROGEN DEPRIVATION THERAPY ON INSOMNIA SYMPTOMS, FATIGUE, MOOD, AND HOT FLASHES IN MEN WITH NON-METASTATIC PROSTATE CANCER
    Van Wijk, Megan
    Garland, Sheila N.
    Wall, Kayla
    Sathya, Jinka
    Thoms, John
    SLEEP, 2019, 42
  • [10] COMORBIDITY BURDEN AND INCREMENTAL COST OF FRACTURES IN MEDICARE MEN WITH NON-METASTATIC PROSTATE CANCER TREATED WITH ANDROGEN DEPRIVATION THERAPY
    Yong, C.
    Onukwugha, E.
    Mullins, C. D.
    Zuckerman, I. H.
    Hussain, A.
    Naslund, M.
    VALUE IN HEALTH, 2015, 18 (03) : A159 - A159
12345